Post Categories
Blog post not found!
Resiliency in CRO Operations During the COVID-19 Pandemic
A Conversation with QPS Holdings LLC Chairman, President and Chief Executive Officer, Ben Chien, PhD NOVEMBER 2020 As QPS Holdings LLC Chairman President, and…
Resiliency in CRO Operations During the COVID-19 Pandemic
November 23, 2020
A Conversation with QPS Holdings LLC Chairman, President and Chief Executive Officer, Ben Chien, PhD NOVEMBER 2020 As QPS Holdings LLC Chairman President, and…
What Field Researchers Can Teach Us About Quarantine and Isolation
As countries around the world move through various stages of quarantine and restrictions on public life, many people are finding themselves more isolated than…
![Scientific research station Almirante Brown Station in Antarctica](https://www.qps.com/wp-content/uploads/2020/11/Scientific-research-station-Almirante-Brown-Station-in-Antarctica.jpg)
What Field Researchers Can Teach Us About Quarantine and Isolation
November 16, 2020
As countries around the world move through various stages of quarantine and restrictions on public life, many people are finding themselves more isolated than…
QPS COVID-19 Testing Capabilities
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…
![Gloved hands handling COVID-19 test tube](https://www.qps.com/wp-content/uploads/2020/10/Gloved-hands-handling-COVID-19-test-tube.jpg)
QPS COVID-19 Testing Capabilities
November 11, 2020
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…
Gene Therapy and Inherited Retinal Diseases
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…
![Gene therapy, gene editing](https://www.qps.com/wp-content/uploads/2020/11/Gene-therapy-gene-editing.jpg)
Gene Therapy and Inherited Retinal Diseases
November 9, 2020
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…
Oligonucleotides: Innovations in Antivirals for Novel Viruses
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…
![Model of DNA, scientists working in background](https://www.qps.com/wp-content/uploads/2020/10/Model-of-DNA-scientists-working-in-background.jpg)
Oligonucleotides: Innovations in Antivirals for Novel Viruses
November 2, 2020
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…
UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…
![Two scientists in PPE examine vaccine, write on clipboard](https://www.qps.com/wp-content/uploads/2020/10/Two-scientists-in-PPE-examine-vaccine-write-on-clipboard.jpg)
UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
October 29, 2020
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
Introduction RNA based drugs are a promising new class of therapeutics with tremendous potential for treating a wide range of diseases. There are various…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…